Upregulation of fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer

Journal of Investigative Dermatology

Volumn 131, Issue 10, 2011, Pages 2139-2142

  Kao, Wynn H ^a,b   Riker, Adam I ^c   Kushwaha, Deepa S ^d   Ng, Kimberly ^d   Enkemann, Steven A ^e   Jove, Richard ^f   Buettner, Ralf ^f   Zinn, Pascal O ^d   Sánchez, Néstor P ^a   Villa, Jaime L ^g   D'Andrea, Alan D ^d   Sánchez, Jorge L ^a   Kennedy, Richard D ^d   Chen, Clark C ^d   Matta, Jaime L ^g  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c Ochsner Cancer Institute   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; BRCA2 PROTEIN; CYCLIN A; CYCLIN E; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA PROTEIN; GAMMA INTERFERON; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P53; STAT1 PROTEIN; TEMOZOLOMIDE; TRANSCRIPTION FACTOR E2F; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; DNA ALKYLATION; DNA CROSS LINKING; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; DNA REPLICATION; DRUG POTENTIATION; EXCISION REPAIR; FANCONI ANEMIA; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MELANOMA; MICROARRAY ANALYSIS; NONHUMAN; NONMELANOMA SKIN CANCER; PATHOGENESIS; PRIMARY CUTANEOUS MELANOMA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CANCER; SKINFOLD THICKNESS; SQUAMOUS CELL CARCINOMA; UPREGULATION; XERODERMA PIGMENTOSUM;

EID: 80052823272     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.181     Document Type: Letter

References (15)

1. Chen CC, Taniguchi T, D'Andrea A (2007) The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents. J Mol Med 85:497-509 (Pubitemid 46701659)
2. Condie A, Powles RL, Hudson CD et al. (2002) Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. Leuk Lymphoma 43:1849-53 (Pubitemid 34874021)
3. Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54 (Pubitemid 34716871)
4. Hazlehurst LA, Enkemann SA, Beam CA et al. (2003) Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res 63:7900-6 (Pubitemid 37466725)
5. Hoskins EE, Gunawardena RW, Habash KB et al. (2008) Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene 27:4798-808
6. Jacquemont C, Taniguchi T (2007) Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res 67:7395-405 (Pubitemid 47206570)
7. Kee Y, D'Andrea AD (2010) Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 24:1680-94
8. Liebetrau W, Budde A, Savoia A et al. (1997) p53 activates Fanconi anemia group C gene expression. Hum Mol Genet 6:277-83 (Pubitemid 27078084)
9. Ma DJ, Li SJ, Wang LS et al. (2009) Temporal and spatial profiling of nuclei-associated proteins upon TNF-alpha/NF-kappaB signaling. Cell Res 19:651-64
10. Nitta M, Kozono D, Kennedy R et al. (2010) Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy. PLoS ONE 5:e10767
11. Pang Q, Fagerlie S, Christianson TA et al. (2000) The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hemato-poietic growth factors. Mol Cell Biol 20:4724-35 (Pubitemid 30396119)
12. Taniguchi T, Garcia-Higuera I, Andreassen PR et al. (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414-20
13. Vaughn JP, Cirisano FD, Huper G et al. (1996) Cell cycle control of BRCA2. Cancer Res 56:4590-4 (Pubitemid 26338053)
14. Yarde DN, Oliveira V, Mathews L et al. (2009) Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma. Cancer Res 69: 9367-75
15. Zaidi MR, Davis S, Noonan FP et al. (2011) Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature 469: 548-53